Erectile dysfunction is a common (affecting 10-20 million men in the USA) and multifactorial
disease due to organic and/or psychological factors that strongly impairs the quality of life in …

The First International Conference on the Management of Erectile Dysfunction, co-chaired
by JF Eid and A Nehra was held in Chicago, Illinois on March 3±4 2000. The First …

Abstract Purpose: The American Urological Association convened the Clinical Guidelines
Panel on Erectile Dysfunction to analyze the literature regarding available methods for …

Introduction: Treatment options for erectile dysfunction (ED) have evolved over the last two
decades, particularly after the introduction of phosphodiesterase type-5 inhibitors (PDE5Is) …

Advances in the Treatment of Organic Erectile Dysfunction Page 1 Advances in the Treatment
of Organic Erectile Dysfunction EDWARD D. KIM and LARRY I. LIPSHULTZ Baylor College of …

Erectile dysfunction (ED) is defined as the consistent inability to obtain or maintain an
erection for satisfactory sexual relations. Data from the Massachusetts Male Aging Study …

Ten years ago, the inhibition of Rho kinase by intracavernosal injection of Y-27632 was
found to induce an erectile response. This effect did not require activation of nitric oxide …

Introduction Although oral phosphodiesterase 5 inhibitors represent a first choice and long-
term option for about half of all patients with erectile dysfunction (ED), self-injection therapy …

Erectile dysfunction (ED) is defined as the inability to achieve and maintain a penile erection
adequate for satisfactory sexual intercourse. It is a significant male health problem of global …

Introduction Intracavernosal injection (ICI) of a vasoactive agent has been an important part
of the diagnosis, evaluation, and treatment of erectile dysfunction (ED) since its initial …